Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Kopelman ZA, Tian C, Tumas J, Phippen NT, Tarney CM, Hope ER, Winkler SS, Jokajtys S, Kucera CW, Chan JK, Richardson MT, Kapp DS, Hamilton CA, Leath CA 3rd, Jones NL, Rocconi RP, Farley JH, Secord AA, Cosgrove CM, Powell MA, Klopp A, Walker JL, Fleming GF, Bateman NW, Conrads TP, Maxwell GL, Darcy KM.
Kopelman ZA, et al. Among authors: jones nl.
Gynecol Oncol. 2024 Apr;183:103-114. doi: 10.1016/j.ygyno.2024.03.026. Epub 2024 Apr 8.
Gynecol Oncol. 2024.
PMID: 38593674